Literature DB >> 21471101

Dysregulation of allergic airway inflammation in the absence of microbial colonization.

Tina Herbst1, Anke Sichelstiel, Corinne Schär, Koshika Yadava, Kurt Bürki, Julia Cahenzli, Kathy McCoy, Benjamin J Marsland, Nicola L Harris.   

Abstract

RATIONALE: The incidence of allergic disorders is increasing in developed countries and has been associated with reduced exposure to microbes and alterations in the commensal bacterial flora.
OBJECTIVES: To ascertain the relevance of commensal bacteria on the development of an allergic response, we used a model of allergic airway inflammation in germ-free (GF) mice that lack any exposure to pathogenic or nonpathogenic microorganisms.
METHODS: Allergic airway inflammation was induced in GF, specific pathogen-free (SPF), or recolonized mice by sensitization and challenge with ovalbumin. The resulting cellular infiltrate and cytokine production were measured.
MEASUREMENTS AND MAIN RESULTS: Our results show that the total number of infiltrating lymphocytes and eosinophils were elevated in the airways of allergic GF mice compared with control SPF mice, and that this increase could be reversed by recolonization of GF mice with the complex commensal flora of SPF mice. Exaggerated airway eosinophilia correlated with increased local production of Th2-associated cytokines, elevated IgE production, and an altered number and phenotype of conventional dendritic cells. Regulatory T-cell populations and regulatory cytokine levels were unaltered, but GF mice exhibited an increased number of basophils and decreased numbers of alveolar macrophages and plasmacytoid dendritic cells.
CONCLUSIONS: These data demonstrate that the presence of commensal bacteria is critical for ensuring normal cellular maturation, recruitment, and control of allergic airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471101     DOI: 10.1164/rccm.201010-1574OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  148 in total

Review 1.  Update in asthma 2011.

Authors:  Shamsah Kazani; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2012-07-01       Impact factor: 21.405

Review 2.  Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions.

Authors:  Yvonne J Huang; John R Erb-Downward; Robert P Dickson; Jeffrey L Curtis; Gary B Huffnagle; MeiLan K Han
Journal:  Transl Res       Date:  2016-06-23       Impact factor: 7.012

Review 3.  Obesity and severe asthma.

Authors:  Hiroki Tashiro; Stephanie A Shore
Journal:  Allergol Int       Date:  2018-12-01       Impact factor: 5.836

Review 4.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

Review 5.  Role of the Microbiome in Food Allergy.

Authors:  Hsi-En Ho; Supinda Bunyavanich
Journal:  Curr Allergy Asthma Rep       Date:  2018-04-05       Impact factor: 4.806

Review 6.  Lungs, microbes and the developing neonate.

Authors:  Barbara B Warner; Aaron Hamvas
Journal:  Neonatology       Date:  2015-06-05       Impact factor: 4.035

Review 7.  Gut microbes and adverse food reactions: Focus on gluten related disorders.

Authors:  Heather J Galipeau; Elena F Verdu
Journal:  Gut Microbes       Date:  2014

8.  Molecular Biology of Eosinophils: Introduction.

Authors:  Paige Lacy; Helene F Rosenberg; Garry M Walsh
Journal:  Methods Mol Biol       Date:  2021

9.  Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses.

Authors:  Shin Yong Park; Xuefang Jing; Dipika Gupta; Roman Dziarski
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

Review 10.  Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches.

Authors:  Kohei Hasegawa; Orianne Dumas; Tina V Hartert; Carlos A Camargo
Journal:  Expert Rev Respir Med       Date:  2016-06-16       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.